LUNG SAFE研究:性别对ARDS患者管理与结局的影响
基于LUNG SAFE前瞻性队列中2377例接受有创机械通气的ARDS患者,比较女性(905例,38%)与男性(1472例,62%)的管理与结局。女性接受更高潮气量(8.2±2.1 vs 7.2±1.6 mL·kg-1;p<0.0001)和小潮气量通气比例更低(50% vs 74%;p<0.0001),身高≤1.69 m的女性更少接受小潮气量通气;总体住院死亡率相似(均为40.2%),但重症确诊ARDS女性死亡风险更高(男性vs女性OR 0.35,95%CI 0.14-0.83)。
要点
- 女性ARDS患者更少接受小潮气量通气,潮气量及平台压、驱动压更高。
- 身高≤1.69 m的女性接受小潮气量通气的可能性显著更低。
- 重症确诊ARDS女性死亡风险更高,提示需优化女性通气管理。
核心结论
- 身高较矮的女性ARDS患者更少接受小潮气量通气,重症确诊ARDS女性死亡风险更高。
研究设计与样本
- LUNG SAFE前瞻性队列研究,纳入2377例接受有创机械通气的ARDS患者,其中女性905例(38%)、男性1472例(62%)。
- 分析性别对死亡率、ICU及住院时长、有创机械通气时长的影响,并校正临床与地理混杂因素。
主要发现
- 临床医生对ARDS的识别率及疾病严重程度谱无性别差异。
- 女性潮气量高于男性(8.2±2.1 vs 7.2±1.6 mL·kg-1;p<0.0001),平台压和驱动压也更高。
- 接受小潮气量通气的女性为50%,男性为74%(p<0.0001);身高≤1.69 m的女性更少接受小潮气量通气。
- 存活女性有创机械通气时长及住院时长较男性缩短。
- 总体住院死亡率女性40.2%、男性40.2%;重症确诊ARDS中男性vs女性OR 0.35(95%CI 0.14-0.83)。
临床怎么用
- 对女性ARDS患者应关注潮气量设置,尤其身高≤1.69 m者需按预测体重规范小潮气量通气。
- 重症确诊ARDS女性死亡风险更高,临床应加强性别特异的通气管理与监测。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
RATIONALE: We wished to determine the influence of sex on the management and outcomes in acute respiratory distress syndrome (ARDS) patients in the Large Observational Study to Understand the Global Impact of Severe Acute Respiratory Failure (LUNG SAFE). METHODS: We assessed the effect of sex on mortality, intensive care unit and hospital length of stay, and duration of invasive mechanical ventilation (IMV) in patients with ARDS who underwent IMV, adjusting for plausible clinical and geographic confounders. FINDINGS: Of 2377 patients with ARDS, 905 (38%) were female and 1472 (62%) were male. There were no sex differences in clinician recognition of ARDS or critical illness severity profile. Females received higher tidal volumes (8.2±2.1 versus 7.2±1.6 mL·kg-1; p<0.0001) and higher plateau and driving pressures compared with males. Lower tidal volume ventilation was received by 50% of females compared with 74% of males (p<0.0001). In shorter patients (height ≤1.69 m), females were significantly less likely to receive lower tidal volumes. Surviving females had a shorter duration of IMV and reduced length of stay compared with males. Overall hospital mortality was similar in females (40.2%) versus males (40.2%). However, female sex was associated with higher mortality in patients with severe confirmed ARDS (OR for sex (male versus female) 0.35, 95% CI 0.14-0.83). CONCLUSIONS: Shorter females with ARDS are less likely to receive lower tidal volume ventilation, while females with severe confirmed ARDS have a higher mortality risk. These data highlight the need for better ventilatory management in females to improve their outcomes from ARDS.
引用
- McNicholas BA, Madotto F, Pham T, et al. Demographics, management and outcome of females and males with acute respiratory distress syndrome in the LUNG SAFE prospective cohort study. Eur Respir J. 2019. PMID: 31346004. doi:10.1183/13993003.00609-2019
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。